Testing a new drug for children with autism
Part of Mental health clinical trials.
This trial tests a new medicine (NV01-A02) in children aged 6 to 15 who have autism. The goal is to see if the drug is safe and helpful for managing autism symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 6 and 15 years old
- Your child must have a confirmed diagnosis of autism spectrum disorder
- Your child must weigh between 16 and 70 kilograms (about 35 to 154 pounds)
- Your child should not have other serious mental health or medical conditions that could interfere with the study
- Your child should not have uncontrolled seizures, severe self-injury, or hearing loss
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational tablet (TTYP01) to see if it can help adolescents and children with autism spectrum disorder (ASD). The goal is to find out if the drug improves symptoms and is safe for this age group.
This trial tests if a medicine called suramin (KZ101) can help with social challenges in boys with autism. It's a 12-week study at one location, and families must be able to visit the site easily.
This trial tests SCI-210, a cannabis-based medicine, to see if it is safe and can improve challenging behaviors in children and young adults with autism. You may be asked to complete regular check-ins about behavior and development over the study.
This trial tests a new medicine called NTI164 in people aged 6 to 25 with moderate to severe autism. It aims to see if the treatment can help with symptoms.
This trial studies whether N-acetylcysteine, a medicine taken by mouth, can improve autism-related restricted and repetitive behaviors in children. It looks at children who are showing at least moderate severity in these behaviors and may involve brain testing for safety reasons.
This trial tests a device called the NeuroCytotron to see if it can help people with autism. It is for individuals aged 3 to 50 who have a confirmed autism diagnosis and are medically stable.
Hear when a new Autism Spectrum Disorder (ASD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.